Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BRLI NYSE:DGX NYSE:DVA NYSE:LH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBRLIBrilliant Acquisition$4.70$0.00$0.00▼$0.00$8.51M-0.1287,171 shs370,983 shsDGXQuest Diagnostics$178.13+7.0%$174.95$137.71▼$182.38$18.58B0.491.01 million shs2.70 million shsDVADaVita$146.09+4.8%$140.11$131.76▼$179.60$11.03B1.11810,769 shs970,731 shsLHLabcorp$252.34+3.8%$253.65$205.98▼$265.72$21.12B0.82654,512 shs1.01 million shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBRLIBrilliant Acquisition0.00%0.00%0.00%0.00%0.00%DGXQuest Diagnostics+0.08%-0.83%-6.90%-3.26%+14.33%DVADaVita-1.19%-2.77%+2.04%+3.33%+1.09%LHLabcorp-0.37%-2.78%-7.33%+10.21%+14.88%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBRLIBrilliant AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ADGXQuest Diagnostics4.869 of 5 stars2.32.04.24.73.82.52.5DVADaVita4.3565 of 5 stars2.02.00.04.52.31.73.8LHLabcorp4.3421 of 5 stars2.32.02.54.23.22.51.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBRLIBrilliant Acquisition 0.00N/AN/AN/ADGXQuest Diagnostics 2.69Moderate Buy$186.074.46% UpsideDVADaVita 2.00Hold$164.5012.60% UpsideLHLabcorp 2.57Moderate Buy$276.089.41% UpsideCurrent Analyst Ratings BreakdownLatest BRLI, LH, DGX, and DVA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/18/2025DGXQuest DiagnosticsUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$176.00 ➝ $175.007/18/2025LHLabcorpUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$284.00 ➝ $282.007/10/2025LHLabcorpHsbc Global ResSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold7/10/2025LHLabcorpHSBCSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold$260.007/9/2025LHLabcorpEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$260.00 ➝ $285.006/25/2025LHLabcorpBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingCautious ➝ Cautious6/25/2025LHLabcorpBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetEqual Weight ➝ Equal Weight$250.00 ➝ $275.006/11/2025LHLabcorpMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$270.00 ➝ $283.005/19/2025DVADaVitaTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$170.00 ➝ $164.005/12/2025LHLabcorpTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$274.00 ➝ $290.005/6/2025LHLabcorpPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$260.00 ➝ $280.00(Data available from 7/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBRLIBrilliant AcquisitionN/AN/AN/AN/A($1.89) per shareN/ADGXQuest Diagnostics$10.16B1.96$14.41 per share12.36$61.38 per share2.90DVADaVita$12.82B0.86$19.80 per share7.38$4.83 per share30.25LHLabcorp$13.01B1.62$23.19 per share10.88$96.27 per share2.62Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBRLIBrilliant Acquisition-$970KN/A0.00∞N/AN/AN/A-4.47%N/ADGXQuest Diagnostics$871M$7.9122.5216.982.338.81%15.11%6.65%7/22/2025 (Estimated)DVADaVita$936.34M$10.0914.4811.490.976.63%176.11%4.66%8/5/2025 (Estimated)LHLabcorp$746M$8.6529.1714.391.545.55%15.27%6.97%7/24/2025 (Estimated)Latest BRLI, LH, DGX, and DVA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/5/2025Q2 2025DVADaVita$2.70N/AN/AN/A$3.36 billionN/A7/24/2025Q2 2025LHLabcorp$4.12N/AN/AN/A$3.49 billionN/A7/22/2025Q2 2025DGXQuest Diagnostics$2.57$2.62+$0.05$2.47$2.73 billion$2.76 billion5/12/2025Q1 2025DVADaVita$1.75$2.00+$0.25$2.00$3.22 billion$3.22 billion4/29/2025Q1 2025LHLabcorp$3.73$3.84+$0.11$2.52$3.41 billion$3.35 billion4/22/2025Q1 2025DGXQuest Diagnostics$2.15$2.21+$0.06$1.94$2.63 billion$2.65 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBRLIBrilliant AcquisitionN/AN/AN/AN/AN/ADGXQuest Diagnostics$3.201.80%N/A40.46%14 YearsDVADaVitaN/AN/AN/AN/AN/ALHLabcorp$2.881.14%N/A33.29%N/ALatest BRLI, LH, DGX, and DVA DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/10/2025LHLabcorpquarterly$0.721.11%8/28/20259/11/20255/14/2025DGXQuest Diagnosticsquarterly$0.801.86%7/7/20257/7/20257/21/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBRLIBrilliant AcquisitionN/A0.990.99DGXQuest Diagnostics0.841.441.31DVADaVita23.181.251.20LHLabcorp0.681.841.60Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBRLIBrilliant Acquisition11.82%DGXQuest Diagnostics88.06%DVADaVita90.12%LHLabcorp95.94%Insider OwnershipCompanyInsider OwnershipBRLIBrilliant Acquisition69.80%DGXQuest Diagnostics8.16%DVADaVita2.00%LHLabcorp0.84%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBRLIBrilliant AcquisitionN/A1.81 million548,000Not OptionableDGXQuest Diagnostics56,000111.64 million102.53 millionOptionableDVADaVita76,00075.50 million73.99 millionOptionableLHLabcorp70,00083.70 million83.00 millionOptionableBRLI, LH, DGX, and DVA HeadlinesRecent News About These CompaniesLabcorp Holdings Inc. (NYSE:LH) Shares Sold by M. Kulyk & Associates LLCJuly 22 at 12:44 PM | marketbeat.comWhat Analyst Projections for Key Metrics Reveal About Labcorp (LH) Q2 EarningsJuly 21 at 10:21 AM | zacks.comClifford Swan Investment Counsel LLC Increases Stock Position in Labcorp Holdings Inc. (NYSE:LH)July 21 at 10:07 AM | marketbeat.comLabcorp Q2 Earnings Preview: Diagnostics Strength in FocusJuly 21 at 9:31 AM | zacks.comLabcorp (NYSE:LH) Given New $282.00 Price Target at UBS GroupJuly 21 at 3:55 AM | americanbankingnews.comLabcorp Holdings Inc. (NYSE:LH) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies AheadJuly 20 at 9:47 PM | finance.yahoo.comMorningstar Investment Services LLC Sells 1,628 Shares of Labcorp Holdings Inc. (NYSE:LH)July 20 at 6:18 AM | marketbeat.comUBS Group Lowers Labcorp (NYSE:LH) Price Target to $282.00July 19 at 2:58 PM | marketbeat.comWill Labcorp (LH) Beat Estimates Again in Its Next Earnings Report?July 18, 2025 | zacks.comLabcorp Holdings Earnings Preview: What to ExpectJuly 18, 2025 | msn.comMy Favorite Options Trade For This WeekJuly 18, 2025 | benzinga.comLabcorp Holdings (LH) Earnings Expected to Grow: Should You Buy?July 17, 2025 | zacks.comLabcorp Holdings Inc. (NYSE:LH) Shares Sold by Cooke & Bieler LPJuly 17, 2025 | marketbeat.comPettee Investors Inc. Acquires Shares of 8,780 Labcorp Holdings Inc. (NYSE:LH)July 17, 2025 | marketbeat.comMassachusetts Financial Services Co. MA Sells 1,289 Shares of Labcorp Holdings Inc. (NYSE:LH)July 17, 2025 | marketbeat.comLabcorp (LH) to Release Earnings on ThursdayJuly 17, 2025 | marketbeat.comDakota Wealth Management Takes Position in Labcorp Holdings Inc. (NYSE:LH)July 16, 2025 | marketbeat.comLabcorp Holdings Inc. stock underperforms Tuesday when compared to competitorsJuly 15, 2025 | marketwatch.comNew York State Common Retirement Fund Sells 2,200 Shares of Labcorp Holdings Inc. (NYSE:LH)July 15, 2025 | marketbeat.comMQS Management LLC Buys New Position in Labcorp Holdings Inc. (NYSE:LH)July 13, 2025 | marketbeat.comLabcorp (NYSE:LH) Downgraded to Hold Rating by Hsbc Global ResJuly 13, 2025 | americanbankingnews.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir Soon3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military SpendBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI Defense3 Semiconductor Stocks Poised to Surge on AI SpendingBy Chris Markoch | June 25, 2025View 3 Semiconductor Stocks Poised to Surge on AI Spending3 AI Infrastructure Stocks With Strong Growth, Not HypeBy Chris Markoch | June 26, 2025View 3 AI Infrastructure Stocks With Strong Growth, Not HypeBRLI, LH, DGX, and DVA Company DescriptionsBrilliant Acquisition NASDAQ:BRLIBrilliant Acquisition Corporation operates as a blank check company. It focuses on acquiring; engaging in share exchange and share reconstruction; purchasing the assets; entering into contractual arrangements; and engaging in similar business combination with one or more businesses. The company was founded in 2019 and is based in Shanghai, China.Quest Diagnostics NYSE:DGX$178.13 +11.68 (+7.02%) Closing price 03:58 PM EasternExtended Trading$173.63 -4.50 (-2.53%) As of 05:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.DaVita NYSE:DVA$146.09 +6.66 (+4.78%) Closing price 03:58 PM EasternExtended Trading$146.66 +0.57 (+0.39%) As of 05:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.Labcorp NYSE:LH$252.34 +9.30 (+3.82%) Closing price 03:58 PM EasternExtended Trading$251.82 -0.52 (-0.20%) As of 05:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Block Levels Up: What S&P 500 Inclusion Means for Investors Steel Dynamics Stock Steady on Long-Term Prospects A Bullish Storm Is Brewing for High-Yield Verizon’s Share Price Forget the Hype—TSMC Is the AI Stock That Actually Delivers Rigetti Soars 30% on Latest Quantum Leap: What It Means Long-Term Domino’s Delivers Another Discounted Entry for Income Investors Palantir Bulls and Bears Set for an August Showdown 3 Reasons Palo Alto Networks Is Becoming a Wall Street Favorite Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.